ETFIQData as of Nov 13, 2026. · etfiq.com/funds/nvox

NVOX Fact Sheet: Defiance Daily Target 2X Long NVO ETF

Share
$11.04
close, Nov 13, 2026

Over the year to Nov 13, 2026, NVOX returned −48.1% in total and charged 1.31% a year.

1-year total return
−48.1%
NVO −11.3% to Nov 13, 2026
Expense ratio
1.31%
a year
Net assets
$33m
on Nov 12, 2026
Net flow, last 5 trading days
−$2.4m
daily basis to Nov 12, 2026

Growth of $10,000, 1 year

NVOX $5,188 −48.1% · NVO $8,873 −11.3% · Total return, distributions reinvested, Nov 13, 2025 to Nov 13, 2026.

Returns

WindowTotal return
1 month+16.9%
3 months−21.7%
Year to date−49.6%
1 year−48.1%
Since launch−93.2%

Total return, distributions reinvested, each window to Nov 13, 2026.

Facts

Aims to return twice the daily move of Novo Nordisk A/S (NVO) · First traded Dec 3, 2024 · Benchmark NVO

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, NVOX Fact Sheet: Defiance Daily Target 2X Long NVO ETF. Data as of Nov 13, 2026. https://etfiq.com/funds/nvox/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/nvox.